Literature DB >> 22100691

Oppositional defiant disorder in adults with ADHD.

Frederick W Reimherr1, Barrie K Marchant, John L Olsen, Paul H Wender, Reid J Robison.   

Abstract

OBJECTIVE: Oppositional defiant disorder (ODD) is the most common comorbid condition in childhood ADHD. This trial was prospectively designed to explore ODD symptoms in ADHD adults.
METHOD: A total of 86 patients in this placebo-controlled, double-blind trial of methylphenidate transdermal system (MTS) were categorized based on the presence of ODD symptoms in childhood and adulthood, and then were compared for baseline and outcome differences.
RESULTS: In all, 42% met Diagnostic and Statistical Manual of Mental Disorders (4th ed.; DSM-IV) criteria for ODD as adults and were significantly more impaired on measures of ADHD, personality disorder, and substance abuse and 27% had childhood ODD that had resolved. Childhood and adult ODD symptoms were significantly correlated. ODD and ADHD symptoms improved significantly with MTS (p < .001), and the most consistently significant results were found in participants with adult ODD.
CONCLUSION: A total of 69% met criteria for ODD as children and/or adults. Understanding how ODD interacts with ADHD to impact personality disorder, substance abuse, and treatment response has important clinical, social, and theoretical implications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22100691     DOI: 10.1177/1087054711425774

Source DB:  PubMed          Journal:  J Atten Disord        ISSN: 1087-0547            Impact factor:   3.256


  5 in total

1.  Oppositional Defiant Disorder Dimensions: Associations with Traits of the Multidimensional Personality Model among Adults.

Authors:  Rapson Gomez; Vasileios Stavropoulos
Journal:  Psychiatr Q       Date:  2019-12

2.  The latent structure of oppositional defiant disorder in children and adults.

Authors:  Tammy D Barry; David K Marcus; Christopher T Barry; Emil F Coccaro
Journal:  J Psychiatr Res       Date:  2013-09-03       Impact factor: 4.791

Review 3.  Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.

Authors:  Kim Boesen; Asger Sand Paludan-Müller; Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Cochrane Database Syst Rev       Date:  2022-02-24

4.  Long-Term Efficacy of Psychosocial Treatments for Adults With Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review.

Authors:  Carlos López-Pinar; Sonia Martínez-Sanchís; Enrique Carbonell-Vayá; Javier Fenollar-Cortés; Julio Sánchez-Meca
Journal:  Front Psychol       Date:  2018-05-04

5.  The ADHD Concomitant Difficulties Scale (ADHD-CDS), a Brief Scale to Measure Comorbidity Associated to ADHD.

Authors:  Javier Fenollar-Cortés; Luis J Fuentes
Journal:  Front Psychol       Date:  2016-06-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.